Analystreport

GW Pharmaceuticals PLC- (NASDAQ: GWPH) had its price target raised by analysts at Morgan Stanley to $238.00. They now have an "overweight" rating on the stock.

GW PHARMACEUTICALS PLC AMERICA  (GWPH) 
Last gw pharmaceuticals plc america earnings: 11/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gwpharm.com/investor-relations